Td Asset Management Inc Protagonist Therapeutics, Inc Transaction History

Td Asset Management Inc

$107 Billion
Q3 2024

A detailed history of Td Asset Management Inc transactions in Protagonist Therapeutics, Inc stock. As of the latest transaction made, Td Asset Management Inc holds 172,202 shares of PTGX stock, worth $7.07 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

172,202

Previous 148,302 16.12%

Holding current value

$7.07 Million

Previous $5.14 Million 50.6%

% of portfolio

0.01%

Previous 0.01%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 01, 2024	BUY	$33.72 - $47.33 $805,908 - $1.13 Million	23,900 Added 16.12%	172,202 $7.74 Million
Q2 2024 Aug 02, 2024	BUY	$24.66 - $34.8 $982,701 - $1.39 Million	39,850 Added 36.74%	148,302 $5.14 Million
Q1 2024 May 08, 2024	SELL	$21.79 - $32.15 $51,162 - $75,488	-2,348 Reduced 2.12%	108,452 $3.14 Million
Q3 2023 Oct 27, 2023	BUY	$16.68 - $23.66 $924,072 - $1.31 Million	55,400 Added 100.0%	110,800 $1.85 Million
Q2 2023 Aug 09, 2023	BUY	$18.02 - $29.36 $475,728 - $775,104	26,400 Added 91.03%	55,400 $1.53 Million
Q1 2023 May 10, 2023	BUY	$10.78 - $25.38 $312,620 - $736,020	29,000 New	29,000 $667,000
Q2 2022 Aug 04, 2022	SELL	$7.06 - $25.52 $125,964 - $455,327	-17,842 Closed	0 $0
Q1 2022 May 10, 2022	SELL	$23.34 - $36.08 $354,768 - $548,416	-15,200 Reduced 46.0%	17,842 $422,000
Q4 2021 Feb 10, 2022	SELL	$17.63 - $37.1 $246,820 - $519,400	-14,000 Reduced 29.76%	33,042 $1.13 Million
Q3 2021 Nov 09, 2021	SELL	$12.95 - $49.69 $282,310 - $1.08 Million	-21,800 Reduced 31.67%	47,042 $834,000
Q2 2021 Aug 11, 2021	BUY	$25.57 - $44.88 $188,476 - $330,810	7,371 Added 11.99%	68,842 $3.4 Million
Q1 2021 May 14, 2021	BUY	$19.02 - $31.15 $194,365 - $318,321	10,219 Added 19.94%	61,471 $1.59 Million
Q4 2020 Feb 16, 2021	BUY	$18.49 - $25.13 $220,012 - $299,021	11,899 Added 30.24%	51,252 $1.03 Million
Q2 2020 Aug 13, 2020	BUY	$6.19 - $18.84 $243,595 - $741,410	39,353 New	39,353 $695,000

Others Institutions Holding PTGX

# of Institutions

246

Shares Held

56.5M

Call Options Held

76.3K

Put Options Held

114K

View Full List

About Protagonist Therapeutics, Inc

Ticker PTGX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 49,084,100
Market Cap $2.01B
Description
Protagonist Therapeutics, Inc., a biopharmaceutical company, discovers and develops peptide-based therapeutic drugs to address hematology and blood disorders, and inflammatory and immunomodulatory diseases. It is developing rusfertide (PTG-300), an injectable hepcidin mimetic that is in Phase II clinical trials for the treatment of patients with...

More about PTGX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Td Asset Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Td Asset Management Inc with notifications on news.

Account

Td Asset Management Inc Protagonist Therapeutics, Inc Transaction History